0973-7510 Journal of Pure and Applied Microbiology 2581-690X DR. M.N. Khan 10.22207/JPAM.16.SPL1.15 Prevention, Vaccination, Management and Infection Control of Monkeypox Outbreak: an Update Global Recommendation for the Next Year 2023 Ahmed Sirwan Khalid Department of Pediatric, Rania Pediatric & Maternity Teaching Hospital, Rania, Sulaimani, Kurdistan region, 46012, Iraq. Department of Nursing, University of Raparin, Rania, Sulaimani, Kurdistan region, 46012, Iraq. 30 12 2022 16 Suppl 1 3189 3191 Copyright © 2022 The Author(s) 2022 This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.https://creativecommons.org/licenses/by/4.0/

A sudden increase in human monkeypox infections that began in non-endemic nations in May 2022 has sparked concerns about a new global infectious threat. The number of people who are vulnerable to infection with MPXV is growing worldwide. On July 23, 2022, the World Health Organization (WHO) announced that the recent outbreaks of monkeypox (MPX), an infectious sickness caused by the monkeypox virus (MPXV), have been declared a global public health emergency. As of November 26, 2022, there have been 80.850 confirmed cases and 55 deaths across 110 countries and territories. The present report highlights recommendations for prevention, vaccination, management, and infection control of the probable monkeypox outbreak.

 Keywords Monkeypox Monkeypox Virus Vaccination Treatment Management Infection Control